This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Vilnius University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Edita Capkauskaite: Innovator in Biomedicine
Introduction
Edita Capkauskaite is a prominent inventor based in Vilnius, Lithuania. She has made significant contributions to the field of biomedicine through her innovative research and development of novel compounds. Her work focuses on the inhibition of enzymes that play a crucial role in disease progression.
Latest Patents
Edita holds 1 patent for her invention titled "Selective inhibitors of carbonic anhydrase." This patent discloses novel compounds, specifically benzenesulfonamides of general formulas (I) and (II). These compounds are designed to be used as active ingredients in pharmaceutical formulations, as they effectively inhibit enzymes involved in various diseases. Additionally, the patent outlines methods of treatment utilizing these compounds.
Career Highlights
Edita is affiliated with Vilnius University, where she conducts her research and collaborates with fellow scientists. Her work has garnered attention for its potential applications in medical treatments and therapies.
Collaborations
Edita has worked alongside notable colleagues, including Daumantas Matulis and Andrius Zaksauskas. Their collaborative efforts have contributed to advancing research in the field of biomedicine.
Conclusion
Edita Capkauskaite's innovative work in developing selective inhibitors of carbonic anhydrase showcases her commitment to improving healthcare through scientific research. Her contributions are paving the way for new therapeutic options in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile